Michael Danquah

Early LIfe

Dr. Michael Danquah was born and raised in Ghana, where he earned his Bachelor's degree in Chemical Engineering with First Class Honors from Kwame Nkrumah University of Science and Technology. He later pursued further education in the United States, obtaining a Master’s degree in Chemical Engineering from the University of Kentucky and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center.

Personal Life

Dr. Michael’s personal life reflects his deep passion for leveraging technology to enhance education. He is the founder of several educational technology companies, including Bevinzey, RxCalculations, StudySocius, Brainaly, and Cleverposse. Each of these platforms reflects his commitment to improving learning experiences through innovation. His personal drive is evident in the way he balances his research and business ventures with a focus on making a lasting impact on students and professionals.

Career

Dr. Michael’s personal life reflects his deep passion for leveraging technology to enhance education. He is the founder of several educational technology companies, including Bevinzey, RxCalculations, StudySocius, Brainaly, and Cleverposse. Each of these platforms reflects his commitment to improving learning experiences through innovation. His personal drive is evident in the way he balances his research and business ventures with a focus on making a lasting impact on students and professionals. Like

Danquah M., Pharmaceutical Calculations: 1001 Questions with Answers (2017). CreateSpace,
Danquah M. (2017) Review of Handbook of Porphyrin Science with Application to Chemistry, Physics, Material Science, Engineering, Biology and Medicine. Volume 40: Nanoorganization of Porphyrinoids. J. Nat. Prod. 80:1232-1232
Ibrahim Q., Patel R., Boamah E., Ajayi D., and Danquah M. (2017) Gene Expression Profiling of Triple Negative Breast Cancer Cells Treated with Afatinib. Journal of Pharmaceutical Research International 19:1-13
Shah P., Djisam R., Damulira H., Aganze., and Danquah M. (2016) Embelin Inhibits Proliferation, Induces Apoptosis and Alters Gene Expression Profiles in Breast Cancer Cells. Pharmacological Reports 68:635-644

Wen D., Danquah M., Chaudhary A.K., and Mahato R.I. (2015) Small Molecules Targeting microRNAfor Cancer Therapy. J Control Release 219:237-47

Boamah E., Ibrahim Q., Kwinji L., Patel R., Ajayi D., and Danquah M. (2015) EGFR Inhibitors inCombination with Cyclopamine as Chemotherapeutic Strategy for Treating Breast Cancer. Synergy 2:7-18
Wen D., Chitkara D., Wu H., Danquah M., Patil R., Miller D.D., and Mahato R.I. (2014) LHRH-Conjugated Micelles for Targeted Delivery of Antiandrogen to Treat Advanced Prostate Cancer. Pharmaceutical Research 31:2784-2795
Danquah M. (2014) Polycarbonate Micelles for Cancer Therapy. Journal of Cancer Science and Therapy 6: 310 - 313.
Danquah M., Fujiwara T., and Mahato R.I. (2013) Lactic Acid and Carbonate-based Crosslinked Polymeric Micelles for Drug Delivery. Journal of Polymer Science Part A: Polymer Chemistry 51: 347-362
Danquah M., and Mahato R.I. (Eds) Emerging Trends in Cell and Gene Therapy (2013). Springer, New York, NY.
Chitkara D., Singh S., Kumar V., Danquah M., Behrman S.W., Kumar N., Mahato R.I. (2012) Micellar Delivery of Cyclopamine and Gefitinib for Treating Pancreatic Cancer. Molecular Pharmaceutics 9: 2350-2357.
Mundra V., Danquah M., Li W., Miller D.D., and Mahato R.I. (2012) Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent. Pharmaceutical Research 29: 3064-3074